The Latest
-
Down 55%, are Xero shares the most overlooked bargain now?
-
Champion Iron finalises acquisition of Norway’s Rana Gruber
-
Why this HALO focused ASX ETF outperformed over the last month
-
Telix Pharmaceuticals announces US$40m Regeneron radiopharma deal